Concepedia

Christian C. Felder

CC

Statistics

Publications

111

Citations

15.1K

H-Index

64

Active since

1983

Affiliations

Eli Lilly (United States)(Current)

National Institute of Mental Health

National Institute of Diabetes and Digestive and Kidney Diseases

National Institutes of Health

Monash University

Christian C. Felder is an author at Eli Lilly (United States) specializing in pharmacology, neuropharmacology, and medicine.

ORCID

Publications per year

1983–2023

111

Publications

111

Activation and allosteric modulation of a muscarinic acetylcholine receptor

Andrew C. Kruse, Aaron M. Ring, Aashish Manglik et al. · Nature · 2013 · 909 citations · Full text

, , +14

Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors.

Christian C. Felder, Kelly E. Joyce, Eileen M. Briley et al. · Molecular Pharmacology · 1995 · 879 citations

, , +7

Concurrent Stimulation of Cannabinoid CB1 and Dopamine D2 Receptors Augments cAMP Accumulation in Striatal Neurons: Evidence for a G<sub>s</sub>Linkage to the CB1 Receptor

Michelle Glass, Christian C. Felder · Journal of Neuroscience · 1997 · 636 citations · Full text

, , +17

Characterization of a Novel Endocannabinoid, Virodhamine, with Antagonist Activity at the CB1 Receptor

Amy C. Porter, John‐Michael Sauer, Michael D. Knierman et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 610 citations

, , +10

Selective Muscarinic Receptor Agonist Xanomeline as a Novel Treatment Approach for Schizophrenia

Anantha Shekhar, William Z. Potter, Jeffrey Lightfoot et al. · American Journal of Psychiatry · 2008 · 559 citations

, , +17

1–5 of 111